Brain signals in schizophrenia: a study of a key protein
Part of Mental health clinical trials.
This study examines how a specific brain protein may be linked to schizophrenia symptoms. It involves simple thinking and hand-movement tasks to see how your brain works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of schizophrenia or schizoaffective disorder
- You must be between 18 and 60 years old
- You must be on the same antipsychotic medication and dose for at least 4 weeks before the study starts
- You must be right-handed
- You must have normal thinking and memory skills
- You must not have substance abuse, other psychiatric conditions, or neurological problems affecting your arms or hearing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at brain chemicals involved in “glutamate” and “GABA” signaling in people with schizophrenia (and separately in healthy volunteers). It may help researchers understand what’s going wrong in the brain and guide future treatments.
This study tests whether using brain scans and genetic tests can help choose the best treatment for people early in their schizophrenia. It will check if these biomarkers can predict who will respond better to medication.
This study tests a non-invasive brain stimulation technique to improve brain connectivity in people with schizophrenia. It may help with symptoms by using magnetic pulses to target specific brain areas.
This study looks at how social thinking and brain structure change over time in people with schizophrenia compared to healthy adults. It uses brain scans to see if iron levels in the brain play a role.
This trial studies how a structured exercise program may affect brain health in people with schizophrenia or schizoaffective disorder. It may help researchers understand whether exercise can support brain function and overall health in this condition.
This study builds a database of brain-signal measurements to help find “biomarkers” that may point to schizophrenia or related mental illnesses. Depending on whether you have a mental health diagnosis or you’re healthy, the study will collect information and brain data to compare groups.
Hear when a new Schizophrenia and Schizoaffective Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.